uniQure
$7.80
24H
Market Cap
Volume
Supply
Price Chart
About uniQure - QURE
uniQure N.V. is a biotechnology company known for its pioneering work in gene therapy, utilizing adeno-associated virus (AAV) vectors to deliver therapeutic genes to target cells. Their research and development focus on severe genetic diseases, including hemophilia and neurological disorders.
What are uniQure's core values and mission statement?
uniQure N.V. is committed to delivering on the promise of gene therapy - single treatments with potentially curative results. They aim to provide patients with life-changing therapies to combat genetic diseases.
Who founded uniQure and when?
uniQure N.V. was founded by a team including Sander van Deventer among others, and the company was established in 1998.
Who leads uniQure?
As of the last update available, Matt Kapusta is the Chief Executive Officer (CEO) at uniQure N.V.
Where is uniQure located, and what is its base country?
uniQure N.V. is headquartered in Amsterdam, the Netherlands, which is its base country.
On which exchanges is uniQure traded?
uniQure N.V. is traded on the Nasdaq Stock Market under the ticker symbol QURE.
Historical data
uniQure (QURE) Price Live Data
The live price of uniQure (QURE) is $7.80, with a trading volume of 652,829 in the last 24 hours. Wrapstocks updates the QURE price in real-time. uniQure is up 4.91% in the last 24 hours. The company has a live market cap of $379,952,480.00 and a supply of 48,743,102 QURE stocks.
uniQure (QURE) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 29 minutes.
